Nitroglycerin Injection, Solution
NDC Package 70518-4232-0
Package Information
Nitroglycerin injection is a medication used to relieve chest pain (angina) in people that have a certain heart condition (coronary artery disease). This formulation utilizes a injection, solution delivery system. Marketed by Remedyrepack Inc., this product is identified by NDC 70518-4232 and is authorized under FDA application ANDA072034.
Identification & Billing
- RxCUI: 237205 - nitroglycerin 50 MG in 10 ML Injection
- RxCUI: 237205 - 10 ML nitroglycerin 5 MG/ML Injection
- RxCUI: 237205 - 10 ML NTG 5 MG/ML Injection
- RxCUI: 237205 - 10 ML TNG 5 MG/ML Injection
- RxCUI: 237205 - nitroglycerin 50 MG per 10 ML Injection
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70518 - Remedyrepack Inc.
- 70518-4232 - Nitroglycerin
- 70518-4232-0 - 25 VIAL, SINGLE-DOSE in 1 TRAY / 10 mL in 1 VIAL, SINGLE-DOSE (70518-4232-1)
- 70518-4232 - Nitroglycerin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70518-4232-0 identifies a specific commercial package of 25 vial, single-dose in 1 tray / 10 ml in 1 vial, single-dose (70518-4232-1) of Nitroglycerin, a human prescription drug labeled by Remedyrepack Inc.. This injection, solution is formulated for intravenous use and contains nitroglycerin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Remedyrepack Inc. on November 14, 2024. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to relieve chest pain (angina) in people that have a certain heart condition (coronary artery disease). It may also be used before physical activities (such as exercise, sexual activity) to help prevent chest pain. Nitroglycerin belongs to a class of drugs known as nitrates. Angina occurs when the heart muscle is not getting enough blood. This drug works by relaxing and widening blood vessels so blood can flow more easily to the heart.
How is this Remedyrepack Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70518423200. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.